The new CEO for Pfizer in Argentina: who is she and what company does she come from?

Pfizer announced that Augustine Ruiz Villamil like your new one country manager in Argentina, Uruguay and Paraguay. It is one of the most relevant passages in the pharmaceutical industry: executive power He comes from the head of the Swiss Novartis subsidiarywhere he previously held office Chief Scientific Director. will replace Nicholas VaquerWHO left a subsidiary of the American giant late last year to take up a global position in the vaccine business.

In the press release on his appointment, it is emphasized that Ruiz Villamil has more than 20 years of experience in the pharmaceutical industry. Doctor, B.Sc Australian Universityhe did an international residency in Indiana University. He joined Novartis in mid-2018, and took over its local presidency June 2021. During his tenure, the press release states, “a high-performance organization was created, made up of different companies (Pharma, Oncology, Sandoz)”.

Before coming to Novartis, since 2016, he was the chief of staff of PAMIduring the proceedings of Carlos Regazzoni (until March 2017) and his successor, Sergio Cassinotti; in both cases, during the presidency Mauricio Macri. Ruiz Villamil came from work international experience in markets like China and Spainin clinical research and development roles for the laboratory Baxter International.

“As part of Pfizer’s ambitions, aimed at developing up to 25 new medicines by 2025, Ruiz Villamil aims to strengthen, integrate and improve all areas and processes of the company in the Argentine region”, said his new employer, whose plant is Soldati, where it produces Ibupiracexports 35% of its production. The Argentine operation is also key in terms of research, one of the reasons why Pfizer was able to quickly adapt to the covid developments that were underway in other diseases.

The new CEO will thus continue the path opened by her predecessor Vaquer, who led the branch for four years. Vaquer had to visit Olivos in the middle of the pandemic to announce to Alberto Fernández the development of tests in the country for the development of a vaccine against Covid. And, of course, everything that followed: from the initially failed nation-state supply contract to the glacier myth, including congressional testimony.

However, the end result of that work –by the middle of last year, Pfizer had already delivered more than 22 million doses– he earned an executive – also a trained doctor – his promotion to global vice president of marketing for vaccines, until the end of 2022.